Tandem Diabetes Care, Inc. (TNDM) is a publicly traded Healthcare sector company. As of September 24, 2026, TNDM trades at $16.39 with a market cap of $1.22B and a P/E ratio of -17.36. TNDM moved +0.03% today. Year to date, TNDM is -23.99%; over the trailing twelve months it is +28.27%. Its 52-week range spans $9.98 to $37.93. Analyst consensus is buy with an average price target of $26.46. Rallies surfaces TNDM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for TNDM, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $16.39 |
| Market Cap | $1.22B |
| P/E Ratio | -17.36 |
| EPS | $-0.92 |
| Dividend Yield | 0.00% |
| 52-Week High | $37.93 |
| 52-Week Low | $9.98 |
| Volume | 4.09K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.04B |
| Net Income | $-63.31M |
| Gross Margin | 56.01% |
15 analysts cover TNDM: 0 strong buy, 8 buy, 7 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $26.46.